OIG Releases Special Fraud Alert on Laboratory Payments to Physicians

by Ballard Spahr LLP
Contact

The Office of the Inspector General (OIG) for the Department of Health and Human Services recently issued a Special Fraud Alert regarding laboratory payments to referring physicians. The Special Fraud Alert reaffirms OIG’s long-standing position that the anti-kickback statute is violated when a clinical laboratory pays a physician for services or provides anything of benefit to the physician, if even one purpose of the payment or benefit is to induce referrals of federal health care program business.

In addition, the OIG addresses two evolving targets: arrangements that “carve out” federal health care programs with the hope of avoiding the federal anti-kickback statute, as well as registry arrangements. This notice should serve as a warning to laboratories using such arrangements to examine their practices and consider whether they should be restructured. The release supplements previous guidance and advisory opinions on the topic, including the 1994 Special Fraud Alert, the OIG Compliance Program Guidance for Clinical Laboratories, and OIG Advisory Opinion No. 05-08 (June 6, 2005).

Blood-Specimen Collection, Processing, and Packaging Arrangements

Certain clinical laboratories that offer diagnostic testing do not have free-standing sites where a patient can have his or her blood drawn and sent to the laboratory for testing. In these situations, the referring physician must collect, process, and prepare the specimen for shipment to the clinical laboratory. The services required of the physician's office may include centrifuging the specimen, keeping it at a certain temperature, and packaging the specimen. Some diagnostic laboratories enter into arrangements with physicians to compensate them for the time and effort involved in this process (Specimen Processing Arrangements). The OIG states that certain characteristics of a Specimen Processing Arrangement may evidence the requisite intent to violate the anti-kickback statute. Such evidence might include:

  • Payment that exceeds fair market value for services actually rendered by a physician
  • Payment for services that are covered by a third party (Such third parties include Medicare; OIG states that Medicare reimburses physicians for process and handling services through a bundled payment.)
  • Payment made on a per-specimen basis for more than one specimen collected in a single patient encounter, or on a per-test, per-patient, or other basis that takes into account the volume or value of referrals
  • Payment conditioned on a specified volume of tests or test panel, especially if the panel includes duplicative tests
  • Payment made to the physician or group practice, even though the specimen collection is performed by an in-office phlebotomist

Perhaps most informative is the OIG’s caution that Specimen Processing Arrangements that carve out federal health care program beneficiaries from a questionable arrangement might still violate the anti-kickback statute if they are merely an attempt to disguise payment for federal health care business. Noting that physicians tend to send all of their tests to one lab for convenience and administrative efficiency, the OIG believes that physicians may still be tempted to refer federal health care program business to the offering laboratories. This is not the first time that the OIG has warned that carve-out arrangements may be at risk under the anti-kickback statute. (See OIG Adv. Op. No. 12-06 (May 25, 2012) and OIG Adv. Op. No. 13-03 (June 7, 2013)).

Registry Payments

The OIG also addresses the practice of some clinical laboratories in establishing, coordinating, and maintaining a database of the demographics, presentation, diagnosis, treatment, outcomes, and other characteristics of patients that have undergone certain tests by the clinical laboratory. The clinical laboratory pays the physician for collecting and reviewing data and answering patient questions (Registry Arrangements).

The OIG states that Registry Arrangements may effectively induce physicians to order medically unnecessary or duplicative testing, or to refer to laboratories that offer Registry Arrangements in lieu of more clinically superior laboratories. The OIG sets forth a list of some of the characteristics that might be evidence of an unlawful purpose, such as:

  • A certain testing frequency is required to be eligible for Registry Arrangements.
  • Multiple tests are ordered to compile comparative data on a patient.
  • Compensation is on a per-patient basis, varies with the volume or value of referrals, or is not fair market value for the services.
  • Documentation of the services provided is lacking.
  • Registry Arrangements are only offered for proprietary tests or disease states associated with those tests.
  • Tests are presented in a panel format on a requisition form, making it difficult for the physician to make an independent decision about which tests are medically necessary.

With this Special Fraud Alert, the OIG has signaled that these arrangements will enjoy intense scrutiny and that the government views these them as "inherently suspect." Clinical laboratories utilizing these arrangements should take a close look at any payments to referring providers. If the arrangement does not already fit within an anti-kickback safe-harbor, the laboratory should seek counsel on how to restructure such arrangements in light of the Special Fraud Alert.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ballard Spahr LLP | Attorney Advertising

Written by:

Ballard Spahr LLP
Contact
more
less

Ballard Spahr LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.